Acute and chronic pain after thoracoscopic surgery
Conditions
Interventions
Thoracic paravertebral nerve block group:Patients were injected with 0.375% ropivacaine 10 ml into the paravertebral space at the two levels of both T6 and T9 (20ml total) on the same side of the sur
Pure general anesthesia group:Pure general anesthesia, do not make thoracic paravertebral block treatment
Sponsors
Second Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Aged 30-80 years old, BMI 18 ~ 30kg / m2, ASA I ~ III grade, thoracoscopic surgery under general anesthesia.
Exclusion criteria
Exclusion criteria: Puncture site infection; coagulation disorders; with nerve conduction disease; heart function, liver and kidney dysfunction; long-term use of non-steroidal drugs; have a history of serious drug allergy; affect the pain score and combined cognitive changes in patients with mental disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total opioid use within 24 hours; 3 months after surgery, patients were followed up by phone for VAS score at rest and coughing, and incidence of chronic pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| the first pressing time of the analgesic pump and demand times within 48 hours;postoperative analgesia satisfaction score;changes of blood pressure and heart rate before and after skin cutting;Patients anesthesia recovery time and extubation time;Postoperative hospital stay; | — |
Countries
China
Contacts
Public ContactZhenzhong Luo
Second Affiliated Hospital of Nanchang University
Outcome results
None listed